Abstract
Simple SummaryAfter the implementation of an internationally recognized histopathological protocol, the rate of complete resections of pancreatic-head cancers has dropped significantly. As recently discovered, the fat surrounding the pancreatic head is infiltrated in most of the patients suffering from pancreatic head cancer. This presumably contributed to the low rates of complete resections. Therefore, these patients show signs of borderline resectability and may benefit from a chemotherapy prior to surgery. The aim of this study was to re-analyze the preoperative CT scans and to correlate those with the histopathological results. We found that the existence of cancerous infiltration of the fat surrounding the pancreas can be predicted by preoperative CT scan and that this in turn can discriminate between patients receiving complete or incomplete resections. Hence, a new standardized radiographic protocol should be implemented and preoperative chemotherapy may be warranted for at risk patients. Summary: The rates of microscopic incomplete resections (R1/R0CRM+) in patients receiving standard pancreaticoduodenectomy for PDAC remain very high. One reason may be the reported high rates of mesopancreatic fat infiltration. In this large cohort study, we used available histopathological specimens of the retropancreatic fat and correlated high resolution CT-scans with the microscopic tumor infiltration of this area. We found that preoperative MDCT scans are suitable to detect cancerous infiltration of this mesopancreatic tissue and this, in turn, was a significant indicator for both incomplete surgical resection (R1/R0CRM+) and worse overall survival. These findings indicate that a neoadjuvant treatment in PDAC patients with CT-morphologically positive infiltration of the mesopancreas may result in better local control and thus improved resection rates. Mesopancreatic fat stranding should thus be considered in the decision for neoadjuvant therapy. Background: Due to the persistently high rates of R1 resections, neoadjuvant treatment and mesopancreatic excision (MPE) for ductal adenocarcinoma of the pancreatic head (hPDAC) have recently become a topic of interest. While radiographic cut-off for borderline resectability has been described, the necessary extent of surgery has not been established. It has not yet been elucidated whether pre-operative multi-detector computed tomography (MDCT) staging reliably predicts local mesopancreatic (MP) fat infiltration and tumor extension. Methods: Two hundred and forty two hPDAC patients that underwent MPE were analyzed. Radiographic re-evaluation was performed on (1) mesopancreatic fat stranding (MPS) and stranding to peripancreatic vessels, as well as (2) tumor diameter and anatomy, including contact to peripancreatic vessels (SMA, GDA, CHA, PV, SMV). Routinely resected mesopancreatic and perivascular (SMA and PV/SMV) tissue was histopathologically re-analyzed and histopathology correlated with radiographic findings. A logistic regression of survival was performed. Results: MDCT-predicted tumor diameter correlated with pathological T-stage, whereas presumed tumor contact and fat stranding to SMA and PV/SMV predicted and correlated with histological cancerous infiltration. Importantly, mesopancreatic fat stranding predicted MP cancerous infiltration. Positive MP infiltration was evident in over 78%. MPS and higher CT-predicted tumor diameter correlated with higher R1 resection rates. Patients with positive MP stranding had a significantly worse overall survival (p = 0.023). Conclusions: A detailed preoperative radiographic assessment can predict mesopancreatic infiltration and tumor morphology and should influence the decision for primary surgery, as well as the extent of surgery. To increase the rate of R0CRM− resections, MPS should be considered in the decision for neoadjuvant therapy.
Highlights
Ductal adenocarcinoma of the pancreatic head is associated with a dismal prognosis, an overall 5-year survival rate of less than 5% and is estimated to become the second leading cause of cancer-related death by 2030 [1]
Fat tissue of thetest dorsal resection margin were evaluated in patients
In 14 (18.2%) of these patients, tumor infiltration in the perifat tissue of the dorsal resection margin were evaluated in 197 patients (82.4%)
Summary
Ductal adenocarcinoma of the pancreatic head (hPDAC) is associated with a dismal prognosis, an overall 5-year survival rate of less than 5% and is estimated to become the second leading cause of cancer-related death by 2030 [1]. A standardized histopathological examination technique including the evaluation of the circumferential resection margin (CRM) was implemented in 2004, according to the recommendations of the Royal College of Pathologists [5,6]. Studies showed a significant influence of this technique on the margin-negative resection rate (R0). The medial pancreatic surface (groove of the portal vein/superior mesenteric vein and superior mesenteric artery) and the dorsal pancreatic resection margin (from inferior caval vein to abdominal aorta) remain the main sites for residual tumor. Positive resection margin rates in these locations are between 44–64% and 46–69%, respectively [6,7,8,9,10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have